Nutrien 過去の業績
過去 基準チェック /46
Nutrienの収益は年間平均-19.2%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間12.4% 1.4%割合で 減少しています。 Nutrienの自己資本利益率は9.6%であり、純利益率は8.9%です。
主要情報
-19.25%
収益成長率
-16.39%
EPS成長率
| Chemicals 業界の成長 | 4.55% |
| 収益成長率 | -1.38% |
| 株主資本利益率 | 9.59% |
| ネット・マージン | 8.88% |
| 次回の業績アップデート | 06 Aug 2026 |
最近の業績更新
Recent updates
ナラティブの更新 • May 03
NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns
The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.
ナラティブの更新 • Apr 19
NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook
The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.ナラティブの更新 • Apr 04
NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns
Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.ナラティブの更新 • Mar 21
NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance
Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.ナラティブの更新 • Mar 07
NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook
The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.ナラティブの更新 • Feb 21
NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns
Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.ナラティブの更新 • Feb 07
NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead
Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.
ナラティブの更新 • Jan 23
NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside
Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.ナラティブの更新 • Jan 09
NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks
Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.ナラティブの更新 • Dec 21
NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing
Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.ナラティブの更新 • Dec 07
NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead
Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.ナラティブの更新 • Nov 23
NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead
Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.ナラティブの更新 • Nov 07
NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny
Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.ナラティブの更新 • Oct 24
Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty
Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.ナラティブの更新 • Oct 09
Global Food Demand And Precision Ag Will Secure Fertilizer Success
Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.分析記事 • Sep 08
With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For
Nutrien Ltd.'s ( TSE:NTR ) price-to-earnings (or "P/E") ratio of 20.1x might make it look like a sell right now...分析記事 • Aug 08
Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Shareholders might have noticed that Nutrien Ltd. ( TSE:NTR ) filed its second-quarter result this time last week. The...分析記事 • Jul 16
Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...分析記事 • Jul 03
A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Nutrien fair value estimate is CA$98.09 Current share price of...
新しいナラティブ • Feb 09
Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations
Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.収支内訳
収支内訳
Nutrien の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 26 | 26,877 | 2,387 | 4,215 | 0 |
| 31 Dec 25 | 25,949 | 2,267 | 4,087 | 0 |
| 30 Sep 25 | 25,671 | 1,809 | 4,080 | 0 |
| 30 Jun 25 | 25,021 | 1,363 | 4,090 | 0 |
| 31 Mar 25 | 24,739 | 527 | 4,118 | 0 |
| 31 Dec 24 | 25,016 | 674 | 4,121 | 0 |
| 30 Sep 24 | 25,556 | 733 | 4,207 | 0 |
| 30 Jun 24 | 25,839 | 790 | 4,222 | 0 |
| 31 Mar 24 | 27,325 | 845 | 4,118 | 0 |
| 31 Dec 23 | 28,082 | 1,258 | 4,094 | 0 |
| 30 Sep 23 | 29,967 | 2,198 | 3,949 | 0 |
| 30 Jun 23 | 32,583 | 3,700 | 3,959 | 0 |
| 31 Mar 23 | 35,466 | 6,853 | 3,992 | 0 |
| 31 Dec 22 | 37,012 | 7,660 | 4,050 | 0 |
| 30 Sep 22 | 36,792 | 7,749 | 4,180 | 0 |
| 30 Jun 22 | 34,612 | 6,889 | 4,101 | 0 |
| 31 Mar 22 | 29,868 | 4,404 | 4,015 | 0 |
| 31 Dec 21 | 26,861 | 3,153 | 3,826 | 0 |
| 30 Sep 21 | 23,642 | 2,268 | 3,663 | 0 |
| 30 Jun 21 | 21,861 | 964 | 3,552 | 0 |
| 31 Mar 21 | 20,514 | 621 | 3,409 | 0 |
| 31 Dec 20 | 20,053 | 459 | 3,324 | 0 |
| 30 Sep 20 | 19,534 | 95 | 3,213 | 0 |
| 30 Jun 20 | 19,470 | 823 | 3,084 | 0 |
| 31 Mar 20 | 19,754 | 916 | 3,052 | 0 |
| 31 Dec 19 | 19,316 | 992 | 3,028 | 0 |
| 30 Sep 19 | 19,671 | 1,336 | 2,889 | 0 |
| 30 Jun 19 | 19,449 | 128 | 2,929 | 0 |
| 31 Mar 19 | 18,862 | 11 | 2,930 | 0 |
| 31 Dec 18 | 18,772 | -31 | 2,891 | 0 |
| 30 Sep 18 | 16,051 | -447 | 2,298 | 0 |
| 30 Jun 18 | 13,376 | 636 | 1,631 | 0 |
| 31 Mar 18 | 6,489 | 47 | 829 | 0 |
| 31 Dec 17 | 4,010 | 154 | 233 | 0 |
| 30 Sep 17 | 3,973 | 196 | 218 | 0 |
| 30 Jun 17 | 3,893 | 261 | 221 | 0 |
| 31 Mar 17 | 3,824 | 230 | 233 | 0 |
| 31 Dec 16 | 3,921 | 199 | 231 | 0 |
| 30 Sep 16 | 4,239 | 478 | 253 | 0 |
| 30 Jun 16 | 4,658 | 679 | 246 | 0 |
| 31 Mar 16 | 5,330 | 975 | 251 | 0 |
| 31 Dec 15 | 5,791 | 1,115 | 258 | 0 |
| 30 Sep 15 | 6,303 | 1,476 | 258 | 0 |
| 30 Jun 15 | 6,402 | 1,511 | 255 | 0 |
質の高い収益: NTRは 高品質の収益 を持っています。
利益率の向上: NTRの現在の純利益率 (8.9%)は、昨年(2.1%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: NTRの収益は過去 5 年間で年間19.2%減少しました。
成長の加速: NTRの過去 1 年間の収益成長率 ( 352.9% ) は、5 年間の平均 ( 年間-19.2%を上回っています。
収益対業界: NTRの過去 1 年間の収益成長率 ( 352.9% ) はChemicals業界0.1%を上回りました。
株主資本利益率
高いROE: NTRの 自己資本利益率 ( 9.6% ) は 低い とみなされます。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/20 22:53 |
| 終値 | 2026/05/20 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Nutrien Ltd. 15 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。52
| アナリスト | 機関 |
|---|---|
| Harriet Li | Accountability Research Corporation |
| Keith Carpenter | ATB Cormark |
| Benjamin Theurer | Barclays |